Tech Entrepreneur Uses ChatGPT to Design Cancer Vaccine for Dying Dog

A Sydney tech entrepreneur turned to a chatbot to brainstorm cancer treatments for his dying dog, then used artificial intelligence to process gigabytes of genetic data to create an mRNA vaccine blueprint. Paul Conyngham, who has 17 years of experience in machine learning and data analysis, partnered with Australia's top scientists to manufacture the world's first personalized canine cancer vaccine. The vaccine, given to his dog Rosie over the Christmas break in 2025, caused one of her tumors to shrink by half. Martin Smith, an associate professor at the University of NSW where the vaccine was developed, said the results raise the question of why similar treatments aren't being rolled out to all humans with cancer. The recovery has astounded researchers at the cutting-edge of human cancer treatments. The breakthrough demonstrates how AI could democratize personalized medicine.

‍